CHPA releases statement on FDA plans to end animal testing
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
Research
Circana report reveals the 2024 U.S. CPG growth leaders
The findings highlight the industry’s shifting dynamics, as smaller CPG companies and private labels take center stage, leveraging innovation and value-driven strategies to outperform their peers.
Circana: Consumers shop at 39 unique retailers a year, focusing on convenience and value
This shift highlights an evolving consumer landscape where value, convenience, and occasion-based spending impact buying behavior, according to recent research by Circana.
Circana reports on the evolution and cross-industry influence of wellness trend
According to Circana, well-being focused consumers have a buying power exceeding $1.1 trillion in the U.S., highlighting the significant market potential for companies that cater to this demand.
New Criteo research reveals unhappiness with online shopping
Only 18% of consumers turn to online shopping to celebrate major life milestones, suggesting digital retail still struggles to replicate the joy of in-person experiences.
Circana reports factors beyond tariffs are already disrupting normal consumer behavior
Rising prices and debt, immigration concerns, and weather are producing material changes to typical retail activity ahead of unknown tariff impacts.
Sai Life Sciences opens state-of-the-art peptide research center
The Peptide Research Center is equipped with automation, robotics, and more. It is designed to support pharmaceutical and biotech innovators with specialized services.
Snacking playing a vital role in consumers' lives according to Circana report
Nearly half of consumers snack three or more times per day.
Hearing aids market to reach $38 billion by 2030
The hearing aids market is set for significant growth over the next decade, driven by rising awareness, increasing cases of hearing impairment, and continuous technological advancements.
Study: Most consumers now opt for private labels
The Consumer Products Engagement report highlights brands' growing challenge in retaining customer loyalty.
Deloitte: GLP-1s drive surge in pharmaceutical R&D returns
GLP-1 therapies emerge as a key driver of industry return on investment.
Olio Labs study shows why women experience more GLP-1 side effects
With the obesity treatment market expected to reach $200 billion by 2031, this study could greatly influence future therapeutic approaches.
NielsenIQ study: Discount retailers and private labels gain ground
Private-label brands are now a primary growth driver for 53% of retailers. Once seen as budget alternatives, they are evolving into premium and innovative choices.
Evaluate releases 2025 Orphan Drug Report
Report reveals orphans’ growth advantage over non-orphans is narrowing, begging the question - are these drugs still a class apart?
New study: Pharmacies can help combat substance abuse
“These findings reinforce the impact of innovative partnerships in improving health outcomes,” says the NACDS Foundation president.
Americans over 55 report optimism for their health and the future
However, an undercurrent of mental health threats loom.